RingConn (Gen 2 / Gen 3)

RingConn, a Shenzhen-based Chinese smart-ring maker, is the subscription-free anchor of the biometric ring market and a deliberate counterpoint to Oura and Whoop, recorded in the biometric form factor. Its Gen 2 ring sells for about $279 with a 10-to-12-day battery and a charging case extending to about 150 days, pairing PPG, skin-temperature, blood-oxygen, and accelerometer sensors with sleep, heart-rate, and a deep-learning sleep-apnea screening feature, and all standard features are free for life with no membership, the core positioning of the brand; the Gen 2 raised about $4.4 million on Kickstarter and the Gen 3 launched in late May 2026 with more than $10 million in pre-orders in about twenty days. Two corrections to common priors are load-bearing. First, RingConn's sleep-apnea and apnea-hypopnea-index feature is not FDA-cleared but wellness and pre-diagnostic: the company's own launch release says it is actively pursuing clearance and carries a not-intended-to-diagnose disclaimer, and the widely repeated claim that RingConn received FDA clearance for blood oxygen or sleep apnea appears only on aggregator sites and conflates it with the Happy Ring, the genuinely FDA-cleared sleep-apnea ring, so RingConn is recorded as not cleared with its 90.7-percent accuracy a vendor claim. Second, RingConn is not subject to an active US import ban: although it was a co-respondent found to infringe in Oura's International Trade Commission case over patent 11,868,178, it settled and Oura granted it a multi-year license to keep selling in the US, so only Ultrahuman's Ring Air carries the active ban. Its clinical-validation posture is wellness-grade and claim-heavy, and its founder identity, funding, and cumulative unit shipments are not reliably verified.

RingConn (Gen 2 / Gen 3) is listed at $199 on the DEPLOY registry. This is an actual sale price on record.

Yes. RingConn (Gen 2 / Gen 3) is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.

Not verified as fully autonomous. RingConn (Gen 2 / Gen 3)'s capabilities on the DEPLOY registry are recorded as teleoperated-assisted, demonstrated-only, or vendor claims (Tracks sleep, Tracks heart health, and Tracks fitness and activity), not independently confirmed to run without a human in the loop.

RingConn (Gen 2 / Gen 3) is made by RingConn, based in Shenzhen, China, founded in 2023.

2 verified deployments of RingConn (Gen 2 / Gen 3) are on the DEPLOY registry, including at China, Asia, United States (multiple hotel chains).

RingConn (Gen 2 / Gen 3) is available for purchase - a real sale price is on record (see the pricing section for the figure and its source).

On the DEPLOY registry, comparable biometric robots to RingConn (Gen 2 / Gen 3) include Blackrock Neuroport Array, BrainQ Non-Invasive BCI, Neko Body Scan, RNS System.

RingConn (Gen 2 / Gen 3) and Blackrock Neuroport Array (Blackrock Neurotech · 5 deployments) are both biometric robots on the DEPLOY registry. RingConn (Gen 2 / Gen 3) has 2 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.

On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, RingConn (Gen 2 / Gen 3) ranks in roughly the top 23% of biometric models tracked by the registry.

RingConn (Gen 2 / Gen 3) is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.

RingConn (Gen 2 / Gen 3) has 1 active incident on record in the DEPLOY registry. 1 incident on record (1 moderate). Most recent: Oct 2025. Retracted incidents are excluded from this count.